Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
Welcome to the International Journal of CAR T-Cell Therapy
We have a curated list of the most noteworthy news avout CAR T-Cell Development, Manufacturing, Therapy and more from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it has activated its CELESTIAL-301 Phase 1 clinical trial at...
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
WASHINGTON, Oct. 8, 2024 -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the recipients of their 2024 Career Development Awards (CDAs) today.Â
Now in its...
The foundation of cancer treatment has, for decades, been based on surgery. This approach drastically changed in the early 1900s with the development of radiation...
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it has activated its CELESTIAL-301 Phase 1 clinical trial at...
NEW YORK, Sept. 24, 2024 | Report with market evolution powered by AI - The Global Immunology Market  size is estimated to grow by USD 65.8 billion from 2024-2028,...
From left to right: in the foreground, Claudia Wu (Shamano Group), Camen S. P. Lima (CancerThera), Jie Jin (Zheijang University), and Hao Mu (Hospital of the Institute of Hematology and Blood Disorders); on the medium level, Lugui Qiu (Peking Union Medical School), Wang Wei (Shamano Group), Francisco Pessine (Institute of Chemistry/Unicamp); in the third plan, Carmino A. de Souza (CancerThera), Celso D. Ramos (CancerThera), Yongke Zhang (IASO BioTherapeutics), Li Li Min (Faculty of Medical Sciences/Unicamp), Maria Carolina S. Mendes (CancerThera), Bruno D. Benites (Hemocentro/Unicamp) and Elvira Correa (CancerThera). (Source of photo: Official website of CEPID CancerThera)
ROCKVILLE, Md. , Sept. 9, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a global leader in T cell-based immunotherapy, will present interim results of...